Alpha 2.0
Login Register
» Articles » PMID: 29449543

CSF3R-mutated Chronic Neutrophilic Leukemia: Long-term Outcome in 19 Consecutive Patients and Risk Model for Survival

Overview
Journal Blood Cancer J
Date 2018 Feb 17
PMID 29449543
Citations 18
Authors
Natasha Szuber
Christy M Finke
Terra L Lasho
Michelle A Elliott
Curtis A Hanson
Animesh Pardanani
Ayalew Tefferi
Affiliations
Soon will be listed here.
Citing Articles

Gln776X and mutations in multiple myeloma associated with chronic neutrophilic leukemia: case report and literature review.

Han Y, Shi Y, Wu T, Zhou J Arch Med Sci. 2025; 20(6):2090-2093.

PMID: 39967925 PMC: 11831355. DOI: 10.5114/aoms/199530.

Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.

Maffei R, Paolini A, Conte B, Riva G, Nasillo V, Creti F Ann Hematol. 2025; 104(1):263-274.

PMID: 39907800 PMC: 11868254. DOI: 10.1007/s00277-025-06232-1.

Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.

Elbaz Younes I, Mroz P, Tashakori M, Hamed A, Sen S Cancers (Basel). 2025; 17(2).

PMID: 39858009 PMC: 11763460. DOI: 10.3390/cancers17020227.

The spectrum of Ph-negative disease: CNL and CSF3R-related disorders.

Hasserjian R Hematology Am Soc Hematol Educ Program. 2024; 2024(1):270-278.

PMID: 39643989 PMC: 11665692. DOI: 10.1182/hematology.2024000555.

Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature review.

Wang S, Wang F, Tu Y, Zhou Y, Tu S, Wang J Ann Hematol. 2024; 103(10):4319-4323.

PMID: 39105740 PMC: 11512872. DOI: 10.1007/s00277-024-05759-z.

References
1.
Elliott M, Pardanani A, Hanson C, Lasho T, Finke C, Belachew A . ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia. Am J Hematol. 2015; 90(7):653-6. DOI: 10.1002/ajh.24031. View
2.
Gunawan A, McLornan D, Wilkins B, Waghorn K, Hoade Y, Cross N . Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent mutations in chronic neutrophilic leukemia. Haematologica. 2017; 102(6):e238-e240. PMC: 5451352. DOI: 10.3324/haematol.2017.163790. View
3.
Reilly J . Chronic neutrophilic leukaemia: a distinct clinical entity?. Br J Haematol. 2002; 116(1):10-8. DOI: 10.1046/j.1365-2141.2002.03234.x. View
4.
Lasho T, Mims A, Elliott M, Finke C, Pardanani A, Tefferi A . Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib. Leukemia. 2014; 28(6):1363-5. DOI: 10.1038/leu.2014.39. View
5.
Arber D, Orazi A, Hasserjian R, Thiele J, Borowitz M, Le Beau M . The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-405. DOI: 10.1182/blood-2016-03-643544. View